{
  "accountCode": "5662516403001",
  "playerCode": "0hVpNUYdY",
  "slidesViewer": true,
  "showSubSlides": false,
  "subSlidesActive": false,
  "chapters": [
    {
      "videoID": "6065602053001",
      "slides": [
        {
          "title": "Introduction",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0001.jpg",
          "time": 0
        },
        {
          "title": "Presenter Disclosure",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0002.jpg",
          "time": 4
        },
        {
          "title": "Empirical, Stratified, and Personalized Medicine",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0003.jpg",
          "time": 42
        },
        {
          "title": "Definitions: Personalized vs. Precision Medicine",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0004.jpg",
          "time": 65
        },
        {
          "title": "What's the difference? Personalized vs. Precision Medicine",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0005.jpg",
          "time": 103
        },
        {
          "title": "Multiple Sclerosis",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0006.jpg",
          "time": 158
        },
        {
          "title": "Relapsing-Remitting Multiple Sclerosis (RRMS)",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0007.jpg",
          "time": 163
        },
        {
          "title": "Pathogenesis of MS",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0008.jpg",
          "time": 221
        },
        {
          "title": "DMT Targets",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0009.jpg",
          "time": 263
        },
        {
          "title": "Evolving Treatment and Management Landscape in MS",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0010.jpg",
          "time": 280
        },
        {
          "title": "Sequencing Strategies",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0011.jpg",
          "time": 331
        },
        {
          "title": "Early Intensive Treatment vs. Escalation",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0012.jpg",
          "time": 385
        },
        {
          "title": "DMT Switching Dynamics",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0013.jpg",
          "time": 403
        },
        {
          "title": "Multiple DMTs Over Lifetime",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0014.jpg",
          "time": 418
        },
        {
          "title": "MS Patient-Related Needs, Preferences, and Factors May Change",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0015.jpg",
          "time": 428
        },
        {
          "title": "Sequencing Treatment Decisions Should Be Personalized",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0016.jpg",
          "time": 450
        },
        {
          "title": "Disease Modifying MS Treatments",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0017.jpg",
          "time": 471
        },
        {
          "title": "DMT Mechanisms of Action",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0018.jpg",
          "time": 472
        },
        {
          "title": "DMT Mechanisms of Action",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0019.jpg",
          "time": 507
        },
        {
          "title": "DMT Mechanisms of Action",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0020.jpg",
          "time": 559
        },
        {
          "title": "Dimethyl Fumarate Known Mechanisms Of Action",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0021.jpg",
          "time": 566
        },
        {
          "title": "Dimethyl Fumarate Known Immunological Effects in RRMS Patients",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0022.jpg",
          "time": 574
        },
        {
          "title": "Dimethyl Fumarate PML Cases",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0023.jpg",
          "time": 584
        },
        {
          "title": "Absolute Lymphocyte Counts (ALC)",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0024.jpg",
          "time": 586
        },
        {
          "title": "DMT-Associated Lymphopenia",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0025.jpg",
          "time": 589
        },
        {
          "title": "Change In Absolute Lymphocyte Count Does Not Correlate With Disease Activity",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0026.jpg",
          "time": 593
        },
        {
          "title": "DMT-Related Subset Changes",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0027.jpg",
          "time": 612
        },
        {
          "title": "Rationale And Study Design",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0028.jpg",
          "time": 670
        },
        {
          "title": "Clinical Characteristics Of Recruited Patients",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0029.jpg",
          "time": 724
        },
        {
          "title": "Immunophenotyping RRMS Patients",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0030.jpg",
          "time": 756
        },
        {
          "title": "Results",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0031.jpg",
          "time": 795
        },
        {
          "title": "Results",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0032.jpg",
          "time": 839
        },
        {
          "title": "T-distributed Stochastic Neighbor Embedding (tSNE) Analysis",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0033.jpg",
          "time": 914
        },
        {
          "title": "SPADE Analysis",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0034.jpg",
          "time": 992
        },
        {
          "title": "CD3+ T Cells And Its Subtypes Are Significantly Affected By FTY And DMF Treatment",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0035.jpg",
          "time": 1077
        },
        {
          "title": "Memory T Cells",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0036.jpg",
          "time": 1135
        },
        {
          "title": "Lymphopenic DMF Patients Have More Naive T Cells And Less Effector Memory T Cells",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0037.jpg",
          "time": 1202
        },
        {
          "title": "Lymphopenic DMF Patients Have More Naive T Cells And Less Effector Memory T Cells",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0038.jpg",
          "time": 1233
        },
        {
          "title": "Frequency of T Helper Cells",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0039.jpg",
          "time": 1301
        },
        {
          "title": "DMF and FTY Treatment Change The Distribution of B Cell Subtypes",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0040.jpg",
          "time": 1334
        },
        {
          "title": "Distribution Of Other Mononuclear Cells",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0041.jpg",
          "time": 1360
        },
        {
          "title": "TCRgd",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0042.jpg",
          "time": 1383
        },
        {
          "title": "Treatment Response Prediction",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0043.jpg",
          "time": 1428
        },
        {
          "title": "Clinical Characteristics Of Recruited Patients For Longitudinal Analysis",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0044.jpg",
          "time": 1441
        },
        {
          "title": "DMF-Treated Patients With And Without Lymphopenia After 1 Year Of Treatment Showed Significant Decreases Over Time in PBMC But Not B And T Cells",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0045.jpg",
          "time": 1467
        },
        {
          "title": "B Cell Populations Do Not Significantly Change Over Time In DMF-N or DMF-L",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0046.jpg",
          "time": 1491
        },
        {
          "title": "Effector Memory Cells And Central Memory Cells",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0047.jpg",
          "time": 1516
        },
        {
          "title": "Role Of Immunosenescence On Cell Subsets",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0048.jpg",
          "time": 1528
        },
        {
          "title": "Results",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0049.jpg",
          "time": 1570
        },
        {
          "title": "Role Of Immunosenescence On Cell Subsets",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0050.jpg",
          "time": 1616
        },
        {
          "title": "PLS-DA For Separation Between DMF Treated Patients DMF-N And DMF-L",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0051.jpg",
          "time": 1685
        },
        {
          "title": "Influence Of Age, Sex And Previous Treatment",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0052.jpg",
          "time": 1699
        },
        {
          "title": "Conclusion",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0053.jpg",
          "time": 1734
        },
        {
          "title": "DMTs Have Different Duration of Immune Effects",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0054.jpg",
          "time": 1748
        },
        {
          "title": "Duration Of Immune Effects",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0055.jpg",
          "time": 1760
        },
        {
          "title": "Duration Of Immune Effects",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0056.jpg",
          "time": 1778
        },
        {
          "title": "Cell Depleters Dynamics Of Reconstitution",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0057.jpg",
          "time": 1801
        },
        {
          "title": "Immunological Considerations For Transitioning Between DMTs",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0058.jpg",
          "time": 1841
        },
        {
          "title": "Vaccine Effectiveness",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0059.jpg",
          "time": 1867
        },
        {
          "title": "Considerations in DMT Selection And Sequencing",
          "imageUrl": "https://storage.googleapis.com/intl_static_files/img/eu_ean2019_ms_symposium/0060.jpg",
          "time": 1907
        }
      ]
    }
  ]
}
